Regenerative Medicine: Rejuvenation and Disease Cure

Q: What led to the creation of RegenerAge, and what main health problems can you prevent?

A: Smart prevention is the best treatment for any disease. Once an illness is part of a person’s life, human regeneration is a great option for health to restructure damaged tissues and cells. Biotechnology advances provide a chance to improve outcomes when a patient needs diverse medical treatments. Using a unique biopharmaceutical product, Bioquantine (BQ-A®), in combination with stem cells we are able to offer an option for those who would like their own bodies to activate the healing process or keep themselves as healthy as they can for as long as possible. We have created a system of different treatments including functional and regenerative based diets, Bioidentical Hormone Replacement Treatments, skin regeneration and aesthetics. From this point, we can guide the patient into adopting a functional style of nutrition because regeneration is borne from a specific diet plus bioidentical hormone replacement treatment, which is the proper use of Human Growth Hormone. Prior to a patient’s regenerative medical performance I have to order different lab tests to decide which patients are candidates for each treatment. Platelets Rich Plasma (PRP) is one option - from the skin surface to knees joints. Another is a stem cell booster or stromal cells, made of the live cells from human placenta. This one has to be implanted within the subcutaneous tissue of the patient’s body. The company’s recent human regeneration project has attracted worldwide media attention after announcing BQ-A extract is going to be used to treat deep coma or brain dead patients. BQ-A contains 93 polypeptides, proteins that work on the development and repairing of human DNA.

Q: What have been some of the results you have seen and what cases demonstrate your success?

A: I was treating a patient suffering from stage 4 pancreatic cancer, which is one of the most aggressive cancers one can contract. After treatment over a few months of using BQ-A, the patient’s lifespan was increased by one year. When I first started treating the patient her prognosis was three to four weeks. I have had positive outcomes with patients suffering from ALS, diabetes, hypertension, rheumatoid arthritis, sclerosis, scleroderma and lupus. Not only can we treat different illnesses but we can also treat patients at a variety of different stages.

Q: How can you expand your business to the more preventive end of the spectrum for patients who are not yet sick or are only just beginning to show symptoms?

A: The more a patient’s health deteriorates the costlier treatment will be. There are three ways we can convince otherwise healthy patients to seek preventive treatment, the first of which is functional nutrition. Secondly, there is bioidentical hormone replacement treatment for women and men over 45 and by maintaining a healthy hormone level in one’s body a patient can stay young for as long as possible. Finally, we offer aesthetic medicine derived from PRP, which can revitalize and regenerate skin all over the body. This includes treatment of cellulite and adipose deposits as well as skin tightening.

Q: Given the fact that regenerative treatment is a new technology, how are you working to make its incorporation into healthcare plans possible?

A: Approved stem cell treatments have been on the market for at least seven years. The use of human placenta to boost stem cells is also an old technique that was discovered about 75 years ago in Russia. In terms of mesenchymal stem cells (MSC) treatments, the new feature we are adding in our system is BQ-A. Our extract itself has been researched for around 30 years and is derived from an amphibian that is able to regenerate itself. It is only now that research has become state of the art, which is why we have recently targeted it.

Q: What are your priorities for 2016-2017?

A: We will start working in different locations in Mexico, and are in talks with private hospitals that are extremely interested in the project. This could be implemented in Puerto Vallarta, Ciudad Juarez, Cancun, Mexico City, Puebla and Cuernavaca. We need to initiate protocols and the first step will be the ReAnima project, which deals with neurological regeneration.